A World-Class Breast Surgeon in Oregon
Learn why Dr. Jewell is the best choice for your breast surgery.Learn More
- Ultherapy®: What It Is and What It’s Not | Part 2 of 3
- The Buzz About Ultherapy® | Part 1 of 3
- Dr. Mark Jewell honored for editing a peer-reviewed supplement on soft tissue support biomaterials in The Aesthetic Surgery Journal.
- Mark Jewell, M.D. presents body contouring research study at the 50th Annual Meeting of the American Society for Aesthetic Plastic Surgery in San Diego, California.
Mark Jewell, MD National Kybella TrainerUpdated November 20, 2015
Dr. Jewell is one of Allergan’s national trainers for its new Kybella injectable drug that is designed to improve fullness in the neck and jawline region. According to Dr. Jewell, Kybella is the first of its type drug that has FDA approval to treat fullness in this region. Training in its use and how to select the proper patient for these treatments is essential to obtaining great results, according to Dr. Jewell. He was involved in some of the earlier work on this drug that helped investigators rate the amount of fullness in the neck and jawline.
“Typically, a Kybella patient will require two or three injection sessions, spaced 6 to 8 weeks apart,” said Dr. Jewell. These fat-reducing injections are well-tolerated, but patients should plan on some swelling afterwards for a few days. For some patients, including men, Kybella offers a great choice to improve fullness that is genetically determined and resistant to diet or exercise.
For more information on Kybella, please visit Dr. Jewell’s website at www.markjewellmd.com